Bridgefront Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.25M Buy
+10,204
New +$2.82M 0.59% 23
2024
Q4
– Sell
-1,780
Closed -$393K – 615
2024
Q3
$393K Sell
1,780
-667
-27% -$138K 0.15% 252
2024
Q2
$481K Buy
+2,447
New +$506K 0.2% 171
2022
Q3
– Sell
-2,194
Closed -$449K – 329
2022
Q2
$449K Buy
2,194
+437
+25% +$92.6K 0.5% 50
2022
Q1
$418K Buy
+1,757
New +$413K 0.51% 50
2021
Q4
– Sell
-1,320
Closed -$255K – 324
2021
Q3
$255K Sell
1,320
-3,244
-71% -$657K 0.27% 180
2021
Q2
$971K Buy
+4,564
New +$964K 0.37% 54
2021
Q1
– Sell
-1,512
Closed -$275K – 711
2020
Q4
$275K Buy
+1,512
New +$257K 0.09% 403

Other funds holding CME

Bridgefront Capital's CME Position: Q2 2026 in Review

Bridgefront Capital opened a new position in CME Group (CME) in Q2 2026: 10,204 shares worth $2.25M. The stake represents 0.59% of the portfolio and ranks #23 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in CME as recently as Q3 2024.

Bridgefront Capital first reported a position in CME in Q4 2020 and has held it in 8 quarters since. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Bridgefront Capital held 10,204 shares of CME Group worth $2.25M as of Q2 2026.
  • CME Group was a new Bridgefront Capital position in Q2 2026.
  • CME Group made up 0.59% of Bridgefront Capital's portfolio in Q2 2026, its #23 holding.
  • Bridgefront Capital first reported a position in CME Group in Q4 2020 and has held it in 8 quarters since.
  • 1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.